Phase 3 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You weigh at least 10 kilograms (about 22 pounds)
- You have been confirmed to have ulcerative colitis (UC)
- You have tried one or more of the following types of treatment — steroid medicines, immune-suppressing medicines, and/or biologic therapies — and either they did not work well enough for you or you could not tolerate them
Who may not be able to join:
- You have a rare genetic condition related to inflammatory bowel disease that started in infancy (confirm with trial site)
- You have been diagnosed with Crohn's disease, indeterminate colitis, microscopic colitis, or other specific types of bowel conditions such as infectious, ischemic, or radiation-related colitis, or active diverticular disease, or you have tunnels or pockets of infection in or around the abdomen or anal area
- You have had surgery to create an ostomy (a bag to collect waste) or an ileoanal pouch (an internal pouch created after bowel removal)
- You currently have, or are suspected of having, a condition affecting the bile ducts called primary sclerosing cholangitis
- You have had a major surgery within the last 6 weeks before the study screening, or you are planning to have a major surgery during the study
- You currently have an active tuberculosis (TB) infection, as shown by a positive TB test, symptoms, or chest scan results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trials, Hoffmann-La Roche
Phone: 888-662-6728 (U.S. and Canada)
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Percentage of Participants with Clinical Remission at Week 12; Percentage of Participants with Clinical Remission at Week 52
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.